New Directions With PARP Inhibitors in Pancreatic Cancer

Decera Clinical Education Oncology Podcast · Feb 21, 2022 · 18m

In this episode, Eileen M. O’Reilly, MD, and Naureen Starling, MD, FRCP, discuss emerging therapeutic strategies involving PARP inhibitor therapy in the treatment of pancreatic cancer. Topics include:

Current treatment landscape and testing in the United States vs the United Kingdom

Testing for molecular subgroups beyond BRCAm

Using PARP inhibitors in earlier stages of the disease

Learning from other cancers, such as prostate, breast, and ovarian

Presenters:

Eileen M. O’Reilly, MD

Winthrop Rockefeller Chair in Medical Oncology

Section Head, Hepatopancreaticobiliary/Neuroendocrine Cancers…